MAXIM PHARMACEUTICALS INC
S-8, EX-23.1, 2000-09-12
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: MAXIM PHARMACEUTICALS INC, S-8, EX-5.1, 2000-09-12
Next: MAXIM PHARMACEUTICALS INC, S-8, EX-23.2, 2000-09-12



<PAGE>
                                                                 EXHIBIT 23.1


                           INDEPENDENT AUDITORS' CONSENT



The Board of Directors
Maxim Pharmaceuticals:

We consent to the use of our report incorporated herein by reference in the
registration statement.





/s/ KPMG LLP
San Diego, California
September 12, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission